Feasibility Study Testing a Sleep Intervention in Prostate Cancer Patients With Insomnia

NCT ID: NCT03444532

Last Updated: 2020-05-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

12 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-03-02

Study Completion Date

2019-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study of a randomized controlled trial aims to evaluate the feasibility of a 12-week sleep program and the randomized controlled trial research procedure. In total 20 participants will be recruited and randomized to the intervention or control group.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This feasibility study of a randomized controlled trial, aims to evaluate the feasibility of a 12-week sleep program consisting on aerobic exercise and cognitive-behavioral therapy. In this study the investigators wish to evaluate the program as well as the randomized controlled trial research procedure.

In total 20 participants will be recruited and randomized to either the intervention group (n=10) or control group (n=10).The intervention group will participate in two exercise sessions each week and four sessions based on cognitive-behavioral therapy for insomnia.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cancer of Prostate Insomnia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

12-week aerobic exercise and cognitive-behavioral therapy

12-week aerobic exercise, two times per week, and cognitive-behavioral therapy for insomnia in total four sessions

Group Type EXPERIMENTAL

12-week aerobic exercise and cognitive-behavioral therapy

Intervention Type BEHAVIORAL

12-week intervention of aerobic exercise training and four session of cognitive-behavioral therapy

Control group

Patients assigned to the control group will receive usual care

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

12-week aerobic exercise and cognitive-behavioral therapy

12-week intervention of aerobic exercise training and four session of cognitive-behavioral therapy

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Prostate cancer
* Receiving treatment with androgen deprivation therapy or in combination with chemotherapy
* Insomnia
* Over 18-yers old
* Understand oral and written Danish
* Written informed consent

Exclusion Criteria

* Medical assessment that does not allow aerobic exercise
* Severe cognitive problems
* Night work during the interventions period
* Exercise training more than three times a week
Minimum Eligible Age

18 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Danish Cancer Society

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Christoffer Johansen

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Christoffer Johansen, PhD, Dr.Med

Role: PRINCIPAL_INVESTIGATOR

Danish Cancer Society Research Center

Katrine Løppenthin, PhD

Role: PRINCIPAL_INVESTIGATOR

Danish Cancer Society Research Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Oncology Department

Næstved, , Denmark

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Denmark

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Sleep-Now

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Transrectal Tumour Oxygen - US Army
NCT00160979 COMPLETED PHASE2